qtr-one adjusted earnings per share $num-two.
qtr-three gaap earnings per share $num-one.
sees fy year-six adjusted earnings per share $num-five to $6.00.
sees fy year-six revenue growth of num-one% to num-two%.
qtrly net sales fell num-one% year-over-year.
qtrly organic net sales decreased num-one% versus qtr-three year-five.
qtr-one sales rose num-two percent to $num-one billion.
qtrly net sales increased num-one% to $1.2 billion.
qtrly global knee business declined num-one% versus qtr-one year-five.
qtr-three adjusted earnings per share $num-one.
sees year-six adjusted earnings per share growth of about num-one%.
sees fy year-six diluted share outstanding to be about num-two million shares.
qtr-two sales fell num-one percent to $num-one billion.
qtrly cash and cash equivalents of $num-two million compared to $1.0 billion at [date], year-five.
qtrly america revenue increased num-one% to $num-one billion.
qtrly global hip business increased num-one%.
